ARKEMA (AKE.PA) Stock Fundamental Analysis
Europe - EPA:AKE - FR0010313833 - Common Stock
53.55 EUR
+0.85 (+1.61%)
We assign a fundamental rating of 5 out of 10 to AKE. AKE was compared to 67 industry peers in the Chemicals industry. AKE has an average financial health and profitability rating. AKE has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
AKE had positive earnings in the past year.
In the past year AKE had a positive cash flow from operations.
AKE had positive earnings in each of the past 5 years.
AKE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AKE has a Return On Assets (1.51%) which is in line with its industry peers.
The Return On Equity of AKE (2.90%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 3.44%, AKE perfoms like the industry average, outperforming 53.73% of the companies in the same industry.
AKE had an Average Return On Invested Capital over the past 3 years of 5.57%. This is in line with the industry average of 7.01%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROIC | 3.44% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
1.3 Margins
Looking at the Profit Margin, with a value of 2.22%, AKE is in line with its industry, outperforming 55.22% of the companies in the same industry.
AKE's Profit Margin has declined in the last couple of years.
AKE has a Operating Margin of 6.35%. This is comparable to the rest of the industry: AKE outperforms 58.21% of its industry peers.
AKE's Operating Margin has declined in the last couple of years.
AKE has a Gross Margin of 19.02%. This is in the lower half of the industry: AKE underperforms 71.64% of its industry peers.
In the last couple of years the Gross Margin of AKE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% |
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AKE is still creating some value.
AKE has more shares outstanding than it did 1 year ago.
AKE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for AKE is higher compared to a year ago.
2.2 Solvency
AKE has an Altman-Z score of 1.87. This is not the best score and indicates that AKE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of AKE (1.87) is worse than 65.67% of its industry peers.
The Debt to FCF ratio of AKE is 16.70, which is on the high side as it means it would take AKE, 16.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AKE (16.70) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.50 indicates that AKE is somewhat dependend on debt financing.
AKE's Debt to Equity ratio of 0.50 is in line compared to the rest of the industry. AKE outperforms 43.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Altman-Z | 1.87 |
ROIC/WACC0.71
WACC4.86%
2.3 Liquidity
AKE has a Current Ratio of 2.73. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.73, AKE is in the better half of the industry, outperforming 79.10% of the companies in the same industry.
A Quick Ratio of 1.92 indicates that AKE should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.92, AKE belongs to the best of the industry, outperforming 83.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
AKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.27%.
Measured over the past 5 years, AKE shows a small growth in Earnings Per Share. The EPS has been growing by 0.10% on average per year.
AKE shows a small growth in Revenue. In the last year, the Revenue has grown by 0.32%.
Measured over the past years, AKE shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-38.27%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.21%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-7.55%
3.2 Future
AKE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.61% yearly.
The Revenue is expected to grow by 2.08% on average over the next years.
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-1.61%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y2.08%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.38, the valuation of AKE can be described as reasonable.
Based on the Price/Earnings ratio, AKE is valued cheaper than 89.55% of the companies in the same industry.
When comparing the Price/Earnings ratio of AKE to the average of the S&P500 Index (26.34), we can say AKE is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.77, the valuation of AKE can be described as very reasonable.
Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 95.52% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.43. AKE is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.38 | ||
| Fwd PE | 8.77 |
4.2 Price Multiples
AKE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AKE is cheaper than 92.54% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AKE is valued a bit cheaper than 77.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.94 | ||
| EV/EBITDA | 4.51 |
4.3 Compensation for Growth
AKE's earnings are expected to decrease with -4.81% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)106.19
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
5. Dividend
5.1 Amount
AKE has a Yearly Dividend Yield of 7.34%, which is a nice return.
Compared to an average industry Dividend Yield of 3.26, AKE pays a better dividend. On top of this AKE pays more dividend than 94.03% of the companies listed in the same industry.
AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.34% |
5.2 History
The dividend of AKE is nicely growing with an annual growth rate of 6.86%!
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
129.52% of the earnings are spent on dividend by AKE. This is not a sustainable payout ratio.
AKE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP129.52%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPA:AKE (11/13/2025, 5:29:59 PM)
53.55
+0.85 (+1.61%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners59.49%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap4.07B
Revenue(TTM)9.54B
Net Income(TTM)210.00M
Analysts73.33
Price Target71.27 (33.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.34% |
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP129.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.64%
Min EPS beat(2)-8.67%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-8.86%
Min EPS beat(4)-18.44%
Max EPS beat(4)-1.73%
EPS beat(8)3
Avg EPS beat(8)-4.83%
EPS beat(12)7
Avg EPS beat(12)1.09%
EPS beat(16)11
Avg EPS beat(16)10.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)8
Avg Revenue beat(16)0.76%
PT rev (1m)-8.22%
PT rev (3m)-14.72%
EPS NQ rev (1m)-26.26%
EPS NQ rev (3m)-33.57%
EPS NY rev (1m)-7.1%
EPS NY rev (3m)-34.13%
Revenue NQ rev (1m)-4.07%
Revenue NQ rev (3m)-4.53%
Revenue NY rev (1m)-1.12%
Revenue NY rev (3m)-2.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.38 | ||
| Fwd PE | 8.77 | ||
| P/S | 0.43 | ||
| P/FCF | 17.94 | ||
| P/OCF | 4.01 | ||
| P/B | 0.56 | ||
| P/tB | 1.9 | ||
| EV/EBITDA | 4.51 |
EPS(TTM)5.16
EY9.64%
EPS(NY)6.11
Fwd EY11.41%
FCF(TTM)2.98
FCFY5.57%
OCF(TTM)13.36
OCFY24.94%
SpS124.15
BVpS95.11
TBVpS28.16
PEG (NY)N/A
PEG (5Y)106.19
Graham Number105.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROCE | 4.88% | ||
| ROIC | 3.44% | ||
| ROICexc | 3.86% | ||
| ROICexgc | 7.22% | ||
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% | ||
| FCFM | 2.4% |
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Debt/EBITDA | 2.56 | ||
| Cap/Depr | 95.75% | ||
| Cap/Sales | 8.36% | ||
| Interest Coverage | 17.14 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 108.1% | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 1.87 |
F-Score5
WACC4.86%
ROIC/WACC0.71
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.27%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.21%
EPS Next Y-35.91%
EPS Next 2Y-13.74%
EPS Next 3Y-4.81%
EPS Next 5Y-1.61%
Revenue 1Y (TTM)0.32%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-7.55%
Revenue Next Year-4.84%
Revenue Next 2Y-1.36%
Revenue Next 3Y0.39%
Revenue Next 5Y2.08%
EBIT growth 1Y-21.16%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year49.9%
EBIT Next 3Y20.73%
EBIT Next 5Y12.81%
FCF growth 1Y-64.53%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-26.48%
OCF growth 3Y7%
OCF growth 5Y-2.92%
ARKEMA / AKE.PA FAQ
What is the ChartMill fundamental rating of ARKEMA (AKE.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to AKE.PA.
What is the valuation status of ARKEMA (AKE.PA) stock?
ChartMill assigns a valuation rating of 6 / 10 to ARKEMA (AKE.PA). This can be considered as Fairly Valued.
How profitable is ARKEMA (AKE.PA) stock?
ARKEMA (AKE.PA) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ARKEMA (AKE.PA) stock?
The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 10.38 and the Price/Book (PB) ratio is 0.56.
How financially healthy is ARKEMA?
The financial health rating of ARKEMA (AKE.PA) is 5 / 10.